Companies are starting to bet big on psychedelic drugs to treat US mental health epidemic
Once dismissed as a "party drug" for its hallucinogenic effects, ketamine is emerging as a novel...
Taking the active ingredients of psychedelics and proving their effectiveness in the clinic...
Set up two years ago, it has attracted more than US$100mln in Series A and B funding that has...
The New York clinical-stage biopharmaceutical company has several drugs in the pipeline capable...
Portfolio includes blockchain firm Arcology, Pressland, which is dedicated to fighting fake...
Proactive Research analyst Ed Stacey says Revive Therapeutics (CSE:RVV)(OTCQB:RVVTF) is a speciality life sciences company focussed on repurposing drugs for rare and infectious diseases and has a pipeline of of three main platforms. One of them is Bucillamine (BUC) which is a medication with a...
Retail & consumer
